| |
| |
 |
Investigation
and diagnosis of urological tumours including the involvement
of: |
| |
|
 |
Radiation
Oncologists |
|
|
|
 |
Medical
Oncologists |
|
|
|
 |
Urologic
Surgical Oncologists |
|
|
|
 |
Radiologists
|
|
|
|
 |
Pathologists
having a special interest in this field |
| |
 |
Multi-disciplinary
approach to clinical management through a weekly consultative
clinico-pathological meeting and outpatient clinic |
| |
 |
Management
of all stages of urological malignancies, including patients
with complex and uncommon presentations |
| |
 |
State-of-the-art
radiotherapy for prostate cancer, including: |
| |
|
 |
Conformal
3-Dimensional Radiotherapy (3DCRT) |
|
|
|
 |
Intensity-Modulated
Radiation Therapy (IMRT) |
|
|
|
 |
Prostate
permanent seed Low Dose Rate Brachytherapy (LDR) |
| |
|
 |
Prostate
temporary needle High Dose Rate Brachytherapy (HDR) |
| |
 |
Access
to clinical trials in: |
| |
|
 |
Prostate |
|
|
|
 |
Bladder |
|
|
|
 |
Testicular
and renal cell tumours |
|
|
|
 |
Including
innovative therapies for hormone-refractory prostate cancer,
and concurrent chemo-irradiation for uroepithelial cancers of
the bladder |
| |
 |
Access
to psychosocial and psycho-oncological supports, as required |
| |
| |